[ Author] Title Type Year
Filters: First Letter Of Last Name is X and Author is Xue, Yu-Juan [Clear All Filters]
Allogeneic hematopoietic stem cell transplantation, especially haploidentical HSCT, may improve long-term survival for high-risk pediatric patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in the tyrosine kinase inhibitor era. Biol Blood Marrow Transplant. 2018.